Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI - Indian registry data.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Association of Physicians of India

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 21046876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of tenecteplase in Indian patients with st-segment elevation myocardial infarction.

  2008cited by this paper
• Pharmacokinetics of a Slower Clearing Tissue Plasminogen Activator Variant, TNK-tPA, in Patients with Acute Myocardial Infarction

  1998cited by this paper
• TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

  1998cited by this paper
• Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

  1997cited by this paper
• Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction

  1997cited by this paper
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study

  1995cited by this paper
• A faster-acting and more potent form of tissue plasminogen activator.

  1994cited by this paper
• Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy

  1993cited by this paper
• Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

  1993cited by this paper
• Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

  1993cited by this paper
• Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.

  1993cited by this paper
• Myocardial infarction in patients with diabetes mellitus.

  1967cited by this paper

• Safety and Efficacy of Tenecteplase among Patients with ST Elevated Myocardial Infarction - Experience in a Tertiary Care Hospital in Bangladesh

  2023cites this paper
• STUDY OF TENECTEPLASE IN PATIENTS WITH ST ELEVATED ACUTE MYOCARDIAL INFARCTION

  2018cites this paper
• Pharmacological Reperfusion Therapy with Tenecteplase in 7,668 Indian Patients with ST Elevation Myocardial Infarction - A Real World Indian Experience.

  2017cites this paper
• Prevalence of glucometabolic disorders in acute coronary syndrome and their prognostic influence in long term cardiovascular outcome

  2016cites this paper